Found 534 hits.
| 59 | Magerl, M., Lammel, V., Siebenhaar, F., Zuberbier, T., Metz, M., and Maurer, M.+: Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp. Dermatol. 2008: 17; 427-435. IF: 3.26 |
o.059
| 69. | Valent, P., Arock, M., Bonadonna, P., Brockow, K., Broesby-Olsen, S., Escribano, L., von Gleixner, K., Grattan, C., Hadzijusufovic, E., Hägglund, H., Hermine, O., Horny, H. P., Kluin-Nelemans, H. C., Maurer, M., Niedoszytko, M., Nedoszyotko, B., Nilsson, G., Oude Elberink, H. N. G., Orfao, Radia, D., A., Reiter, A., Siebenhaar, F., Sotlar, K., Sperr, W. R., Triggiani, M., VanDormaal, J. J., Várkonyi, J., Yavuz, S., and Hartmann, K.: European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. Wien. Klin. Wochenschr. 2012: 124; 807-814. IF: 0.81 |
| 413. | Kulthanan, K., Ungprasert, P., Tapechum, S., Rujitharanawong, C., Kiratiwongwan, R., Munprom, K., Terhorst-Molawi, D., and Maurer, M.+: Vibratory angioedema subgroups, features and treatment: results of a systematic review. J. Allergy Clin. Immunol. Pract. 2021: 9; 971-984. IF: 11.02 |
o.413
| 189 | Prepageran, N.+, Wang, D. Y., Nair, G., and Maurer, M.: The status quo and unmet needs in the management of allergic rhinitis and chronic rhinosinusitis: a Malaysian perspective. Asia Pac. Allergy 2014: 4; 142-148. IF: N/A |
| 42. | Church, M. K., Máspero, J. F., Maurer, M., and Ryan, D.: The scope of pharmacological and clinical effects of modern antihistamines, with a special focus on Rupatadine. World Allergy Organ. J. 2010: 3; S1-S16. IF: N/A |
| 117. | Kocatürk, E., Maurer, M., Metz, M., and Grattan, C.: Looking forward to new targeted treatments for chronic spontaneous urticaria. Clin. Transl. Allergy 2017: 7; 1-10. IF: 3.54
Kocatürk, E., Maurer, M., Metz, M., and Grattan, C.: Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria. Clin. Transl. Allergy 2017: 7; 11 |
r.117 r.117a
| 30. | Maurer, M., Dondji, B., and von Stebut, E.: What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis. Med. Microbiol. Immunol. 2009: 198; 137-146. IF: 3.77 |
| 89. | Harvima, I. T., Levi-Schaffer, F., Draber, P., Friedman, S., Polakovicova, I., Gibbs, B. F., Blank, U., Nilsson, G. and Maurer, M.: Molecular targets on mast cells and basophils for novel therapies. J. Allergy Clin. Immunol. 2014: 134; 530-544. IF: 11.47 |
| 39 | Orinska, Z., Bulanova, E., Budagian, V., Metz, M., Maurer, M. and Bulfone-Paus, S.+: TLR3-induced activation of mast cells modulates CD8+ T cell-recruitment. Blood 2005: 106; 978-987. IF: 10.13 |
| 45 | Weller, K., Foitzik, F., Paus, R., Syska, W., and Maurer, M.+: Mast cells are required for normal healing of skin wounds in mice. FASEB J. 2006: 20; 2366-2368. IF: 6.72 |